Rare disease news, mapped to the diseases behind the headlines. AI-classified across pipeline, policy, funding, science, and community.
Be among the first to receive Kisho Intelligence Briefings
Showing news related to
Showing 1–2 of 2 stories
The SEOM-GEMCAD-TTD clinical guidelines for anal cancer have been published for 2025, providing updated recommendations for diagnosis and treatment. These guidelines aim to enhance clinical practice and improve patient outcomes in anal cancer management.
Read full storyEMA recommends extending the indication of Zynyz (retifanlimab) for treating advanced squamous cell carcinoma of the anal canal in adults. This marks a significant step in immunotherapy options for this patient population.
Get the week's most important rare disease developments — pipeline moves, policy changes, and funding signals — delivered to your inbox every Monday.
Free weekly briefing. Unsubscribe anytime.